Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor
Abstract
Glucose-dependent insulinotropic polypeptide (GIP) is a peptide hormone that exerts crucial metabolic functions by binding and activating its cognate receptor, GIPR. As an important therapeutic target, GIPR has been subjected to intensive structural studies without success. Here, we report the cryo-EM structure of the human GIPR in complex with GIP and a Gs heterotrimer at a global resolution of 2.9 Å. GIP adopts a single straight helix with its N terminus dipped into the receptor transmembrane domain (TMD), while the C-terminus is closely associated with the extracellular domain and extracellular loop 1. GIPR employs conserved residues in the lower half of the TMD pocket to recognize the common segments shared by GIP homologous peptides, while uses non-conserved residues in the upper half of the TMD pocket to interact with residues specific for GIP. These results provide a structural framework of hormone recognition and GIPR activation.
Data availability
Atomic coordinates of the GIP-GIPR-Gs complex have been deposited in the Protein Data Bank under accession code 7DTY and Electron Microscopy Data Bank (EMDB) accession code EMD-30860.All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 2, Figure 1-figure supplement 1 and Figure 4-figure supplement 4.
Article and author information
Author details
Funding
National Natural Science Foundation of China (81872915)
- Ming-Wei Wang
Shanghai Municipal Science and Technology Major Project (2019SHZDZX02)
- Eric Xu
Strategic Priority Research Program of Chinese Academy of Sciences (XDB37030103)
- Eric Xu
Shanghai Municipality Science and Technology Development Fund (18430711500)
- Ming-Wei Wang
Novo Nordisk-CAS Research Fund (NNCAS-2017-1-CC)
- Dehua Yang
Shanghai Science and Technology Development Foundation (18ZR1447800)
- Dehua Yang
The Young Innovator Association of CAS (2018325)
- Lihua Zhao
SA-SIBS Scholarship Program
- Dehua Yang
- Lihua Zhao
National Natural Science Foundation of China (32071203)
- Lihua Zhao
National Natural Science Foundation of China (81773792)
- Dehua Yang
National Natural Science Foundation of China (81973373)
- Dehua Yang
National Natural Science Foundation of China (21704064)
- Qingtong Zhou
National Science and Technology Major Project of China (2018ZX09735-001)
- Ming-Wei Wang
National Science and Technology Major Project of China (2018ZX09711002-002-005)
- Dehua Yang
National Key Basic Research Program of China (2018YFA0507000)
- Ming-Wei Wang
Ministry of Science and Technology of the People's Republic of China (2018YFA0507002)
- Eric Xu
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2021, Zhao et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,435
- views
-
- 741
- downloads
-
- 37
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.
-
- Structural Biology and Molecular Biophysics
The relationship between protein dynamics and function is essential for understanding biological processes and developing effective therapeutics. Functional sites within proteins are critical for activities such as substrate binding, catalysis, and structural changes. Existing computational methods for the predictions of functional residues are trained on sequence, structural, and experimental data, but they do not explicitly model the influence of evolution on protein dynamics. This overlooked contribution is essential as it is known that evolution can fine-tune protein dynamics through compensatory mutations either to improve the proteins’ performance or diversify its function while maintaining the same structural scaffold. To model this critical contribution, we introduce DyNoPy, a computational method that combines residue coevolution analysis with molecular dynamics simulations, revealing hidden correlations between functional sites. DyNoPy constructs a graph model of residue–residue interactions, identifies communities of key residue groups, and annotates critical sites based on their roles. By leveraging the concept of coevolved dynamical couplings—residue pairs with critical dynamical interactions that have been preserved during evolution—DyNoPy offers a powerful method for predicting and analysing protein evolution and dynamics. We demonstrate the effectiveness of DyNoPy on SHV-1 and PDC-3, chromosomally encoded β-lactamases linked to antibiotic resistance, highlighting its potential to inform drug design and address pressing healthcare challenges.